Gene · 5142
Papers1,785
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,785
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review. | Semin Arthritis Rheum | 2023 | 36716599 | PubTator, text mining | PubMed |
| Identification of EMP1 as a critical gene for cisplatin resistance in ovarian cancer by using integrated bioinformatics analysis. | Cancer Med | 2023 | 36708070 | PubTator, text mining | PubMed |
| Peripheral Blood Gene Expression Profile of Infants with Atopic Dermatitis. | JID Innov | 2023 | 36699197 | PubTator, text mining | PubMed |
| BI 1015550: an investigational phosphodiesterase 4B (PDE4B) inhibitor for lung function decline in idiopathic pulmonary fibrosis (IPF). | Expert Opin Investig Drugs | 2023 | 36693635 | PubTator, text mining | PubMed |
| Identification of Novel CSF-Derived miRNAs in Treated Paediatric Onset Spinal Muscular Atrophy: An Exploratory Study. | Pharmaceutics | 2023 | 36678797 | PubTator, text mining | PubMed |
| Preclinical and clinical evidence for suppression of alcohol intake by apremilast. | J Clin Invest | 2023 | 36656645 | PubTator, text mining | PubMed |
| Specific RNA m6A modification sites in bone marrow mesenchymal stem cells from the jawbone marrow of type 2 diabetes patients with dental implant failure. | Int J Oral Sci | 2023 | 36631441 | PubTator, text mining | PubMed |
| Indocyanine-enhanced mouse model of bleomycin-induced lung fibrosis with hallmarks of progressive emphysema. | Am J Physiol Lung Cell Mol Physiol | 2023 | 36625471 | PubTator, text mining | PubMed |
| An Empirical Quantitative Structure-Activity Relationship Equation Assists the Discovery of High-Affinity Phosphodiesterase 4D Inhibitors as Leads to PET Radioligands. | J Med Chem | 2023 | 36608175 | PubTator, text mining | PubMed |
| The Breast Cancer Single-Cell Atlas: Defining cellular heterogeneity within model cell lines and primary tumors to inform disease subtype, stemness, and treatment options. | Cell Oncol (Dordr) | 2023 | 36598637 | PubTator, text mining | PubMed |
| Long-Term Air Pollution, Genetic Susceptibility, and the Risk of Depression and Anxiety: A Prospective Study in the UK Biobank Cohort. | Environ Health Perspect | 2023 | 36598457 | PubTator, text mining | PubMed |
| Selective PDE4 subtype inhibition provides new opportunities to intervene in neuroinflammatory versus myelin damaging hallmarks of multiple sclerosis. | Brain Behav Immun | 2023 | 36584795 | PubTator, text mining | PubMed |
| Pharmacology of orismilast, a potent and selective PDE4 inhibitor. | J Eur Acad Dermatol Venereol | 2023 | 36527389 | PubTator, text mining | PubMed |
| Phosphodiesterase 4B activation exacerbates pulmonary hypertension induced by intermittent hypoxia by regulating mitochondrial injury and cAMP/PKA/p-CREB/PGC-1α signaling. | Biomed Pharmacother | 2023 | 36495666 | PubTator, text mining | PubMed |
| Resistance to Prostaglandin E2 Promotes Monocyte Activation During Chronic HIV Infection. | J Infect Dis | 2023 | 36482781 | PubTator, text mining | PubMed |
| Oral orismilast: Efficacy and safety in moderate-to-severe psoriasis and development of modified release tablets. | J Eur Acad Dermatol Venereol | 2023 | 36478476 | PubTator, text mining | PubMed |
| The Genetically Informed Neurobiology of Addiction (GINA) model. | Nat Rev Neurosci | 2023 | 36446900 | PubTator, text mining | PubMed |
| JAK-STAT Signaling in Inflammatory Breast Cancer Enables Chemotherapy-Resistant Cell States. | Cancer Res | 2023 | 36409824 | PubTator, text mining | PubMed |
| Genetic Predisposition of Both Waist Circumference and Hip Circumference Increased the Risk of Venous Thromboembolism. | Thromb Haemost | 2023 | 36384228 | PubTator, text mining | PubMed |
| Circular RNAs: New layer of complexity evading breast cancer heterogeneity. | Noncoding RNA Res | 2023 | 36380816 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5142/papers?page=17